Market Cap: $2.9517T -0.270%
Volume(24h): $63.1784B -37.120%
  • Market Cap: $2.9517T -0.270%
  • Volume(24h): $63.1784B -37.120%
  • Fear & Greed Index:
  • Market Cap: $2.9517T -0.270%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$94386.437768 USD

-0.55%

ethereum
ethereum

$1813.161244 USD

0.52%

tether
tether

$1.000661 USD

0.01%

xrp
xrp

$2.179198 USD

-0.63%

bnb
bnb

$601.992121 USD

-0.16%

solana
solana

$147.277183 USD

-3.00%

usd-coin
usd-coin

$1.000069 USD

0.00%

dogecoin
dogecoin

$0.179805 USD

-3.96%

cardano
cardano

$0.705168 USD

-2.54%

tron
tron

$0.252008 USD

3.62%

sui
sui

$3.627511 USD

0.28%

chainlink
chainlink

$14.740205 USD

-2.70%

avalanche
avalanche

$22.275506 USD

-2.09%

stellar
stellar

$0.291279 USD

0.57%

toncoin
toncoin

$3.334772 USD

2.72%

Cryptocurrency News Articles

Coeptis Therapeutics Holdings, Inc. and Z Squared Inc. Announce Merger to Create the World's Largest Publicly Traded Dogecoin Mining Company

Apr 27, 2025 at 06:30 am

Under the terms of the deal, Z Squared will become a wholly owned subsidiary of Coeptis (Nasdaq: COEP). Shareholders of Z Squared will receive equity in Coeptis in exchange for 9,000 U.S.-based dogecoin (DOGE) mining machines.

Coeptis Therapeutics Holdings, Inc. and Z Squared Inc. Announce Merger to Create the World's Largest Publicly Traded Dogecoin Mining Company

Coeptis Therapeutics Holdings (Nasdaq: COEP) and Z Squared Inc. announced a definitive merger agreement on April 25, 2025, to create the world’s largest publicly traded dogecoin-focused mining company. As part of the transaction, Coeptis will spin off its biopharmaceutical operations.

Upon completion of the merger, Z Squared will become a wholly owned subsidiary of Coeptis. In exchange for 9,000 U.S.-based dogecoin (DOGE) mining machines, shareholders of Z Squared will receive equity in Coeptis.

The transaction, approved by both boards of directors, is subject to regulatory clearances, Nasdaq listing compliance, and shareholder approval. Closure is anticipated in Q3 2025, with the combined entity rebranding as Z Squared, Inc. and trading on Nasdaq.

Z Squared executives David Halabu and Michelle Burke will helm the merged company as CEO and COO, respectively. Coeptis CEO Dave Mehalick will step down from the board post-closure. Halabu, founder of Group 10 Capital Management, highlighted the merger's aim to provide investors with concentrated exposure to dogecoin's $27 billion market cap.

The new company will dedicate its efforts to mining dogecoin and collecting proof-of-work blockchain rewards. Mehalick elaborated that shareholders will have the opportunity to participate in dogecoin markets while retaining an interest in the spun-off biopharma operations, which will continue independently.

Coeptis' biopharmaceutical divisions, developing cell therapies for cancer and infectious diseases, will continue operating within the spun-off entity. Its technology division, featuring AI and automation tools, will remain with the merged company.

Z Squared, specializing in the mining of DOGE and litecoin (LTC), aims to capitalize on the burgeoning altcoin mining sector. Further transaction details, including leadership economic interests and merger agreement terms, will be filed with the U.S. Securities and Exchange Commission (SEC).

Investors are directed to relevant filings with the SEC for complete information on leadership economic interests and merger terms.

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Apr 27, 2025